Respiratory

With leading health experts warning of a grim few months ahead as the pandemic continues to rage, and as a vaccine launch grows more imminent, this 3-part series explores the impact of existing health disparities on COVID-19 and some potential solutions.

A combination of stay-at-home orders and vape and smoke shop closures contributed to why many young adults and people under 21 years old quit or reduced vaping.

The United States reports record numbers of hospitalizations and deaths due to coronavirus disease 2019 (COVID-19); the CDC updates its quarantine recommendations; Moderna will soon start testing its COVID-19 vaccine in children.

Updating guidelines requires having sufficient information on the elements that are your focus, noted Dan Ouellette, MD, MS, FCCP, senior staff physician and director of the Respiratory Ward at Henry Ford Hospital.

The fall season was accompanied by an urgent warning from the CDC of an impending “twindemic” of coronavirus disease 2019 and influenza. Despite the warnings, Black women are not lining up for vaccinations.

The 2019/2020 GINA guidelines recommend formoterol to produce better long-term outcomes in patients, noted Megan Althoff, MD, PhD, second-year fellow, University of Colorado, Division of Pulmonary Sciences and Critical Care Medicine.

AstraZeneca announced that its vaccine against coronavirus disease 2019 (COVID-19) could be up to 90% effective; FDA grants emergency use authorization (EUA) for antibody cocktail used against COVID-19; spotlighting shortage of specialists to operate ventilators.

A study looked at how 4 types of interventions for children with asthma could impact expenditures and utilization among Medicaid programs.

Pfizer will submit an emergency use authorization for their coronavirus disease 2019 (COVID-19) vaccine; WHO panel recommends against remdesivir; CDC urges Americans to stay put during Thanksgiving.

A study looked at how 4 types of interventions for children with asthma could impact expenditures and utilization among Medicaid programs.

Artificial intelligence (AI) frees up time for clinicians, noted Anthony L. Loschner, MD, assistant professor and associate program director, Critical Care Fellowship Program, Virginia Tech Carilion School of Medicine.

FDA approves a coronavirus disease 2019 (COVID-19) antibody treatment; North Dakota braces hospitals for surging cases; fruit consumption among children is low.

Pfizer said interim data on its coronavirus disease 2019 (COVID-19) vaccine show 90% efficacy; meanwhile, President-elect Joe Biden released the names of his coronavirus advisory board.

In contrast with previous research, a new study suggests that women with interstitial lung disease (ILD) may not need to avoid or terminate pregnancy.

In 2020, there is no item more precious than the N95 respirator mask—a symbol of scarcity due to the systematic failures of coordination, preparation, and policy solutions to respond to the coronavirus disease 2019 pandemic.

An analysis of state vaccination rates from the previous flu season suggest that certain communities may face significant challenges in achieving coronavirus disease 2019 (COVID-19) immunity.

Presenters at CHEST 2020 discussed the concept of how patients with interstitial lung disease (ILD) can develop a progressive fibrosis phenotype and how providers can detect and treat these patients.

Spend time with your patients, discussing both the risks and benefits of a potential coronavirus disease 2019 vaccine, emphasized Maura Abbott, PhD, AOCNP, CPNP, RN, assistant professor of nursing at the Columbia University School of Nursing.

Ransomware attacks threaten US hospitals; the Trump administration purchases 300,000 doses of an antibody drug; CMS releases coverage plan for COVID-19 vaccine and treatments.

Depression and anxiety in pregnant women may disrupt fetal lung development, leading to an increased incidence of asthma and respiratory symptoms in their children.

Maryland’s coronavirus disease 2019 (COVID-19) task force on vulnerable populations leveraged data on social determinants of health to rapidly pinpoint populations most at risk of severe COVID-19 complications.

Study results from a phase 1 trial looking at 2 RNA-based severe acute respiratory syndrome coronavirus 2 vaccine candidates give further insight into the candidates’ safety profiles.

The United States has its first reported of coronavirus disease 2019 (COVID-19) reinfection, in a young male patient with no underlying immune conditions.

The Trump administration signed a $486 million agreement with AstraZeneca to develop a coronavirus disease 2019 (COVID-19) antibody treatment.

Research from the American Cancer Society suggests that more young people are being introduced to nicotine via e-cigarettes.